Xiaomi's first EV is set to surpass production goals of 100,000 units one month early, and now the company expects to complete its EV plant expansion by 2025.
An editorial by Fyodor Urnov lays out the urgent case for major reform in the regulatory appraisal of clinical therapies involving CRISPR gene therapies.